222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Julie Stein Deutsch; Ashley Cimino-Mathews; Elizabeth Thompson; Mariano Provencio; Patrick M Forde; Jonathan Spicer; Nicolas Girard; Daphne Wang; Robert A Anders; Edward Gabrielson; Peter Illei; Jaroslaw Jedrych; Ludmila Danilova; Joel Sunshine; Keith M Kerr; Mia Tran; Judy Bushong; Junliang Cai; Vipul Devas; Jaclyn Neely; David Balli; Tricia R Cottrell; Alex S Baras; Janis Taube

doi:10.1136/jitc-2023-SITC2023.0222-N

Citation Tools

Regular Abstracts – Part 2

Biomarkers, Immune Monitoring and Novel Technologies

222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Deutsch JS, Cimino-Mathews A, Thompson E, et al

222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0222-N

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password